| |
| |
|
| Insider
Information: |
Gyuris Jeno |
| Relationship: |
SVP, Chief Scientific ... |
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
76,131 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$1,141,965 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
76,131 |
|
|
| Total
Value |
$1,141,965 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Aveo Pharmaceuticals Inc |
AVEO |
SVP, Chief Scientific ... |
2015-01-07 |
76,131 |
2011-01-11 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
17 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| AVEO |
Aveo Pharmaceuticals Inc |
SVP, Chief Scientific Officer |
• – – |
2015-01-07 |
4 |
AS |
$0.80 |
$3,589 |
D/D |
(4,484) |
76,131 |
0 |
- |
|
| AVEO |
Aveo Pharmaceuticals Inc |
SVP, Chief Scientific Officer |
• – – |
2015-01-06 |
4 |
D |
$0.00 |
$0 |
D/D |
(13,200) |
80,615 |
0 |
- |
|
| AVEO |
Aveo Pharmaceuticals Inc |
SVP, Chief Scientific Officer |
• – – |
2014-01-30 |
4 |
AS |
$1.64 |
$8,924 |
D/D |
(5,430) |
93,815 |
0 |
- |
|
| AVEO |
Aveo Pharmaceuticals Inc |
SVP, Chief Scientific Officer |
• – – |
2014-01-29 |
4 |
D |
$0.00 |
$0 |
D/D |
(3,200) |
99,245 |
0 |
- |
|
| AVEO |
Aveo Pharmaceuticals Inc |
SVP, Chief Scientific Officer |
• – – |
2013-10-02 |
4 |
D |
$0.00 |
$0 |
D/D |
(48,800) |
102,445 |
0 |
- |
|
| AVEO |
Aveo Pharmaceuticals Inc |
SVP, Chief Scientific Officer |
• – – |
2013-06-26 |
4 |
A |
$0.00 |
$0 |
D/D |
40,000 |
151,245 |
0 |
- |
|
| AVEO |
Aveo Pharmaceuticals Inc |
SVP, Chief Scientific Officer |
• – – |
2013-01-28 |
4 |
AS |
$7.77 |
$5,960 |
D/D |
(767) |
111,245 |
0 |
- |
|
| AVEO |
Aveo Pharmaceuticals Inc |
SVP, Chief Scientific Officer |
• – – |
2013-01-24 |
4 |
A |
$0.00 |
$0 |
D/D |
32,500 |
112,012 |
0 |
- |
|
| AVEO |
Aveo Pharmaceuticals Inc |
SVP, Chief Scientific Officer |
• – – |
2012-05-05 |
4 |
S |
$13.17 |
$39,501 |
D/D |
(3,000) |
83,512 |
0 |
- |
|
| AVEO |
Aveo Pharmaceuticals Inc |
SVP, Chief Scientific Officer |
• – – |
2012-03-07 |
4 |
S |
$13.00 |
$26,000 |
D/D |
(2,000) |
81,512 |
0 |
- |
|
| AVEO |
Aveo Pharmaceuticals Inc |
SVP, Chief Scientific Officer |
• – – |
2012-03-02 |
4 |
S |
$13.16 |
$27,636 |
D/D |
(2,100) |
86,512 |
0 |
- |
|
| AVEO |
Aveo Pharmaceuticals Inc |
SVP, Chief Scientific Officer |
• – – |
2012-03-01 |
4 |
S |
$13.33 |
$26,660 |
D/D |
(2,000) |
88,612 |
0 |
- |
|
| AVEO |
Aveo Pharmaceuticals Inc |
SVP, Chief Scientific Officer |
• – – |
2012-02-29 |
4 |
S |
$13.18 |
$13,175 |
D/D |
(1,000) |
90,612 |
0 |
- |
|
| AVEO |
Aveo Pharmaceuticals Inc |
SVP, Chief Scientific Officer |
• – – |
2012-02-28 |
4 |
S |
$13.08 |
$13,080 |
D/D |
(1,000) |
91,612 |
0 |
- |
|
| AVEO |
Aveo Pharmaceuticals Inc |
SVP, Chief Scientific Officer |
• – – |
2012-02-24 |
4 |
S |
$13.68 |
$20,525 |
D/D |
(1,500) |
92,612 |
0 |
- |
|
| AVEO |
Aveo Pharmaceuticals Inc |
SVP, Head of Research |
• – – |
2011-02-15 |
4 |
A |
$0.00 |
$0 |
D/D |
4,000 |
79,050 |
0 |
- |
|
| AVEO |
Aveo Pharmaceuticals Inc |
SVP, Head of Research |
• – – |
2011-01-11 |
4 |
OE |
$0.48 |
$61,300 |
D/D |
75,050 |
75,050 |
0 |
- |
|
17 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
